Latest JDRF Stories
SAN DIEGO and BETHESDA, Md., March 3, 2015 /PRNewswire/-- ViaCyte, Inc., a privately-held regenerative medicine company with the first stem cell-derived islet replacement therapy for
NEW YORK, Feb.
Unique Approach Aims to Intercept Disease Prior to Onset and Preserve Health of People At-risk of Developing Type 1 Diabetes RARITAN, N.J., Feb.
A newly launched clinical research study at the Icahn School of Medicine at Mount Sinai is examining whether an artificial pancreas (AP) can prevent too low blood sugar levels or hypoglycemia
SAN DIEGO, NEW YORK, and LOS ANGELES, Jan.
Honorees Include Investigators in the Areas of Encapsulated Cell Therapy, Type 1 Diabetes Immunology, and Clinical and Translational Research NEW YORK, Jan.
SAN DIEGO, Jan.
SAN DIEGO and SAN FRANCISCO, Dec.
The CDC estimates that by 2050 one in every three Americans will be living with diabetes.
SAN DIEGO, Nov.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.